These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A novel model based on necroptosis to assess progression for polycystic ovary syndrome and identification of potential therapeutic drugs. Wang M, An K, Huang J, Mprah R, Ding H. Front Endocrinol (Lausanne); 2023; 14():1193992. PubMed ID: 37745699 [Abstract] [Full Text] [Related]
5. Quantitative Proteomics Reveals That a Prognostic Signature of the Endometrium of the Polycystic Ovary Syndrome Women Based on Ferroptosis Proteins. Zhang J, Ding N, Xin W, Yang X, Wang F. Front Endocrinol (Lausanne); 2022; 13():871945. PubMed ID: 35909514 [Abstract] [Full Text] [Related]
6. Identification of key biomarkers for predicting atherosclerosis progression in polycystic ovary syndrome via bioinformatics analysis and machine learning. Zhang W, Wu Y, Yuan Y, Wang L, Yu B, Li X, Yao Z, Liang B. Comput Biol Med; 2024 Dec; 183():109239. PubMed ID: 39396400 [Abstract] [Full Text] [Related]
7. Establishment and Analysis of an Artificial Neural Network Model for Early Detection of Polycystic Ovary Syndrome Using Machine Learning Techniques. Wu Y, Xiao Q, Wang S, Xu H, Fang Y. J Inflamm Res; 2023 Dec; 16():5667-5676. PubMed ID: 38050562 [Abstract] [Full Text] [Related]
11. Identification and validation of HOXD3 and UNC5C as molecular signatures in keloid based on weighted gene co-expression network analysis. Wang H, Zhou Z, Liu Y, Wang P, Chen L, Qi S, Xie J, Tang J. Genomics; 2022 Jul; 114(4):110403. PubMed ID: 35709926 [Abstract] [Full Text] [Related]
14. Dysregulation of ferroptosis-related genes in granulosa cells associates with impaired oocyte quality in polycystic ovary syndrome. Huang J, Fan H, Li C, Yang K, Xiong C, Xiong S, Feng S, Chen S, Wang B, Su Y, Xu B, Yang H, Wang N, Zhu J. Front Endocrinol (Lausanne); 2024 Jul; 15():1346842. PubMed ID: 38390208 [Abstract] [Full Text] [Related]
16. Construction of a competing endogenous RNA network to identify drug targets against polycystic ovary syndrome. Wu T, Gao YY, Tang XN, Li Y, Dai J, Zhou S, Wu M, Zhang JJ, Wang SX. Hum Reprod; 2022 Nov 24; 37(12):2856-2866. PubMed ID: 36223608 [Abstract] [Full Text] [Related]
18. Polycystic ovary syndrome: Identification of novel and hub biomarkers in the autophagy-associated mRNA-miRNA-lncRNA network. Huang J, Huang B, Kong Y, Yang Y, Tian C, Chen L, Liao Y, Ma L. Front Endocrinol (Lausanne); 2022 Nov 24; 13():1032064. PubMed ID: 36523600 [Abstract] [Full Text] [Related]
19. Identification of Hub Genes and Biomarkers between Hyperandrogen and Normoandrogen Polycystic Ovary Syndrome by Bioinformatics Analysis. Zhang T, Liu Y, Li X, Hu B. Comb Chem High Throughput Screen; 2023 Nov 24; 26(1):126-134. PubMed ID: 35379124 [Abstract] [Full Text] [Related]